Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
Abstract Background Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in dev...
Main Authors: | Zhe Huang, Lucija Klaric, Justina Krasauskaite, Stela McLachlan, Mark W. J. Strachan, James F. Wilson, Jackie F. Price |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01493-w |
Similar Items
-
Data from identification of diagnostic biomarkers and metabolic pathway shifts of heat-stressed lactating dairy cows
by: He Tian, et al.
Published: (2015-09-01) -
Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology
by: Mehdi R. Belhaj, et al.
Published: (2021-03-01) -
The Current Applications of Metabolomics in Understanding Endometriosis: A Systematic Review
by: Blake Collie, et al.
Published: (2025-01-01) -
Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage
by: Bosco Seong Kyu Yang, et al.
Published: (2025-01-01) -
Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review
by: Kyle J. Burghardt, et al.
Published: (2023-12-01)